Expert AI Prompts launches its ‘Context-First’ framework to combat small business burnout. Industry-specific prompts end the ...
The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...
Nutritionist Deepsikha Jain offered a simple, food-based strategy for handling common health issues with leafy vegetables.
Granules India Ltd on Thursday said its arm Granules Pharmaceuticals, Inc has received tentative approval from the US health ...
Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, on Thursday announced it has received Tentative Approval (TA) from the U.S. Food and Drug Administration (FDA) for ...
The next era of fintech leadership will likely be defined not by user interface improvements but by data infrastructure.
Analysts anticipate a significant development curve for Ozak AI, with a price increase from its planned $1 listing to $5 in ...
The Skinny Labels, Big Savings Act was introduced on January 9 in an effort to provide “a statutory safe harbor from patent ...
Granules India receives USFDA tentative approval for generic amphetamine extended-release tablets for ADHD treatment.
The $1.6 trillion financial powerhouse Morgan Stanley has filed papers to launch Bitcoin and Solana ETFs, creating interest ...
Granules gets US FDA tentative nod with 180-day exclusivity for generic amphetamine XR tablets: Our Bureau, Bengaluru Thursday, January 8, 2026, 16:15 Hrs [IST] Granules Pharmaceu ...
Hyderabad: Granules Pharmaceuticals, Inc., a wholly owned subsidiary of Granules India Limited, has received tentative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results